Your browser doesn't support javascript.
loading
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.
Afonso, Marta B; Rodrigues, Pedro M; Mateus-Pinheiro, Miguel; Simão, André L; Gaspar, Maria M; Majdi, Amine; Arretxe, Enara; Alonso, Cristina; Santos-Laso, Alvaro; Jimenez-Agüero, Raul; Eizaguirre, Emma; Bujanda, Luis; Pareja, Maria Jesus; Banales, Jesus M; Ratziu, Vlad; Gautheron, Jeremie; Castro, Rui E; Rodrigues, Cecília M P.
Affiliation
  • Afonso MB; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
  • Rodrigues PM; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
  • Mateus-Pinheiro M; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
  • Simão AL; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
  • Gaspar MM; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
  • Majdi A; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
  • Arretxe E; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
  • Alonso C; OWL Metabolomics, Bizkaia Technology Park, Derio, Spain.
  • Santos-Laso A; OWL Metabolomics, Bizkaia Technology Park, Derio, Spain.
  • Jimenez-Agüero R; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain.
  • Eizaguirre E; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain.
  • Bujanda L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain.
  • Pareja MJ; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain.
  • Banales JM; Hospital Universitario de Valme, Sevilla, Andalucía, Spain.
  • Ratziu V; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain.
  • Gautheron J; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
  • Castro RE; Department of Hepatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, Paris, France.
  • Rodrigues CMP; Sorbonne Université, Inserm, Centre de Recherche des Cordeliers (CRC), Paris, France.
Gut ; 70(12): 2359-2372, 2021 12.
Article in En | MEDLINE | ID: mdl-33361348
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lipid Metabolism / Receptor-Interacting Protein Serine-Threonine Kinases / Non-alcoholic Fatty Liver Disease Type of study: Observational_studies Limits: Animals / Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lipid Metabolism / Receptor-Interacting Protein Serine-Threonine Kinases / Non-alcoholic Fatty Liver Disease Type of study: Observational_studies Limits: Animals / Humans Language: En Year: 2021 Type: Article